LumiraDx Analysis

LumiraDx is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of LumiraDx delisted stock analysis is to determine its intrinsic value, which is an estimate of what LumiraDx is worth, separate from its market price. There are two main types of LumiraDx's stock analysis: fundamental analysis and technical analysis.
The LumiraDx stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. LumiraDx is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. LumiraDx Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

LumiraDx Stock Analysis Notes

About 55.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.08. LumiraDx had not issued any dividends in recent years. LumiraDx Limited operates as a point of care diagnostics company. The company was founded in 2014 and is headquartered in London, the United Kingdom. Lumiradx is traded on NASDAQ Exchange in the United States. To find out more about LumiraDx contact the company at 44 11 7284 2535 or learn more at https://www.lumiradx.com.

LumiraDx Investment Alerts

LumiraDx is not yet fully synchronised with the market data
LumiraDx has some characteristics of a very speculative penny stock
LumiraDx has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 254.48 M. Net Loss for the year was (449.19 M) with profit before overhead, payroll, taxes, and interest of 61.02 M.
LumiraDx currently holds about 106.45 M in cash with (162.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42.
Roughly 55.0% of the company outstanding shares are owned by corporate insiders

LumiraDx Upcoming and Recent Events

Earnings reports are used by LumiraDx to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
19th of March 2024
Upcoming Quarterly Report
View
21st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
19th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

LumiraDx Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 249.63 M.

LumiraDx Profitablity

The company has Profit Margin (PM) of (2.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.31.

LumiraDx Outstanding Bonds

LumiraDx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LumiraDx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LumiraDx bonds can be classified according to their maturity, which is the date when LumiraDx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding LumiraDx to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in LumiraDx Stock

If you are still planning to invest in LumiraDx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges